erfusion strategies and aortic clamping techniques for right mini-thoracotomy mitral valve surgery (MVS) have evolved over time; since the first video-assisted mitral valve (MV) repair performed by Alain Carpentier in 1996, new technologies and operation-specific methods have been introduced. Concomitantly, several centers all over the world have adopted this approach and have developed experience in this challenging field. Excellent short-and long-term results have been reported: right mini-thoracotomy MVS has established early and long-term mortality and valve function results comparable with those of the conventional sternotomy approach, as well as less pain, less blood loss, less transfusions, and re-explorations for bleeding, a trend toward shorter hospital stay, faster recovery, less use of rehabilitation resources, and overall healthcare savings.
Different centers support the use of TTC to avoid retrograde balloon manipulation, even if it requires more demanding dissection to allow external clamp positioning and a separate line into the ascending aorta for cardioplegia. 8 A subgroup revision of the International Society for Minimally Invasive Cardiothoracic Surgery showed that the increased risk of neurological complications in the minimal access approach appeared driven by a higher stroke rate in those studies reporting the EAC setting and not the TTC setting. 9 A meta-analysis by Cheng et al. 3 documented a 1.79-fold increase in the relative risk of stroke with the right mini-thoracotomy approach compared with the standard sternotomy approach, but on subgroup analysis, this appeared driven by a higher stroke risk in those studies reporting EAC. 3 These findings are in contrast with more recent reports that demonstrate the safety of the EAC. 4, 8 A study performed by Barbero et al. 7 on 460 consecutive patients who underwent right mini-thoracotomy MVS through three different approaches-RAP with EAC (247, 53.7%) or with TTC (150, 32.6%), and direct ascending aorta cannulation and EAC with the Endodirect (ED) setting (63, 13.7%)-showed that with a correct preoperative assessment and allocation to the most appropriate setting, the rate of early mortality and stroke is low and comparable between the different strategies: overall, no cases of aortic dissection were reported; no differences in terms of stroke rate (1.7% in the EAC, 2% in the TTC, and no cases in the ED group, P) and 30-day mortality (2.1% in the EAC, 2.7% in the TTC, and 1.6% in the ED group, P) were reported. Logistic regression model showed no influences of arterial perfusion and aortic clamping techniques on 30-day mortality and stroke. 7 A multicenter study on right mini-thoracotomy MVS with the EAC setting carried on by Casselman et al. 4 supported this suggestion with a stroke rate of 0.8% (4 of 500 patients) and no aortic dissections.
There are several possible explanations for the discrepancies reported, such as retrospective comparisons of small cohorts with baseline differences, different study periods with different cannulae and clamping devices (Endoreturn vs. Intraclude balloon; Edwards Lifesciences Corp., Irvine, CA USA), lack of peripheral vascular disease assessment during the preoperative screening, and different methods of deairing. The level of experience of the center and its learning curve may also play a critical role in achieving effective and safe results. Indeed, a recent European multicenter report collecting data from high-volume institutions with extensive experience in minimal access MVS and EAC setting showed neurological outcomes completely comparable with those of the standard sternotomy approachmajor stroke occurred in 4 (0.8%) of 500 patients. 10 Fibrillating or beating heart MVS avoids aortic clamping and manipulation of the ascending aorta; however, the safety of deairing can be questioned. The Society of Thoracic Surgeons database shows that fibrillatory arrest carried itself an adjusted threefold higher risk of stroke if compared with aortic cross-clamping. 2 The EndoDirect cannula completes the alternative strategies of cannulation and perfusion for minimal access MVS, avoiding the limitations and the morbidity of a peripheral approach.
Particularly, it allows antegrade flow, which is mandatory in case of severe peripheral arterial disease to prevent arterial injuries, aortic dissection, and strokes. 5 Despite the fact that the production of the EndoDirect cannula has been suspended for regulatory reasons, recent reports underline that it is, definitely, a useful and safe tool to extend right mini-thoracotomy MVS also to high-risk patients.
Current evidence in this field shows that with a proper preoperative assessment of the patient-in terms of past medical history, comorbidities, and anatomy-and a following allocation to the most appropriate approach, the overall rate of neurological events in right mini-thoracotomy MVS is low and comparable between different strategies. Therefore, to guide the patient toward the safest approach, it is paramount to have a full preoperative screening (computed tomography scan or angiography) particularly based on the anatomy of the aortoiliac-femoral vessels. These data allow the surgeon to allocate the patient to the safest perfusion and aortic clamping setting.
In our opinion, all the settings available must be part of a safe right mini-thoracotomy program, and surgeons dedicated to it must be confident with all of them. In this way, the different perfusion and aortic clamping techniques can really be tailored to the individual patient to achieve the best possible clinical outcome.
